Clinical Trial Update: Midodrine for the Treatment of Refractory Hypotension [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing midodrine for refractory hypotension in critically ill patients has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness
• Hypotension

Drugs mentioned

• Midodrine (Midodrine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Hypotension, Critical Illness | Phase 3 | Status: COMPLETED | Results posted: 2019-09-06